ArticleHeliyon2024

Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases.

Liqun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.